.Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01D_CytotoxicAntibioticsAndRelatedSubstances.L01DB04_Aclarubicin.Aclarubicin .Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01D_CytotoxicAntibioticsAndRelatedSubstances.L01DB04_Aclarubicin.Aclarubicin| name: | Aclarubicin | |
| ATC code: | L01DB04 | route: | intravenous |
| compartments: | 2 | |
| dosage: | 40 | mg |
| volume of distribution: | 24 | L |
| clearance: | 44 | L/h/m^2 |
| other parameters in model implementation | ||
Aclarubicin is an anthracycline antibiotic that was previously used as a chemotherapy agent mainly for the treatment of acute leukemia and some solid tumors. Its use has become limited or obsolete in many countries, and it is generally not used as a first-line therapy today due to the availability of better tolerated and more effective alternatives.
Pharmacokinetic parameters estimated for adult patients based on published sources about aclarubicin after intravenous administration.